UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
309.11
+6.49 (2.14%)
At close: Jun 27, 2025, 4:00 PM
308.38
-0.73 (-0.24%)
After-hours: Jun 27, 2025, 7:59 PM EDT
UnitedHealth Group Stock Forecast
Stock Price Forecast
According to 24 professional analysts, the 12-month price target for UnitedHealth Group stock ranges from a low of $270 to a high of $700. The average analyst price target of $436.83 forecasts a 41.32% increase in the stock price over the next year.
Price Target: $436.83 (+41.32%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UnitedHealth Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 6 | 6 |
| Buy | 12 | 12 | 12 | 14 | 15 | 14 |
| Hold | 2 | 2 | 2 | 2 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 23 | 25 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $400 → $385 | Strong Buy | Maintains | $400 → $385 | +24.55% | Jun 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $405 → $418 | Buy | Maintains | $405 → $418 | +35.23% | Jun 20, 2025 |
| Baird | Baird | Buy → Hold Downgrades $356 → $312 | Buy → Hold | Downgrades | $356 → $312 | +0.93% | Jun 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $552 → $353 | Buy | Maintains | $552 → $353 | +14.20% | Jun 3, 2025 |
| Barclays | Barclays | Buy Maintains $362 → $350 | Buy | Maintains | $362 → $350 | +13.23% | Jun 2, 2025 |
Financial Forecast
Revenue This Year
454.09B
from 400.28B
Increased by 13.44%
Revenue Next Year
483.33B
from 454.09B
Increased by 6.44%
EPS This Year
22.77
from 15.51
Increased by 46.80%
EPS Next Year
26.30
from 22.77
Increased by 15.51%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 481.2B | 516.6B | 558.0B | ||
| Avg | 454.1B | 483.3B | 518.3B | ||
| Low | 430.6B | 445.0B | 482.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.2% | 13.8% | 15.5% | ||
| Avg | 13.4% | 6.4% | 7.2% | ||
| Low | 7.6% | -2.0% | -0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.76 | 32.03 | 35.68 | ||
| Avg | 22.77 | 26.30 | 30.30 | ||
| Low | 19.60 | 21.85 | 27.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 79.0% | 40.7% | 35.7% | ||
| Avg | 46.8% | 15.5% | 15.2% | ||
| Low | 26.4% | -4.0% | 3.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.